Literature DB >> 11595116

Radiotherapy and radiosurgical management of brain metastases.

J C Flickinger1.   

Abstract

Out of the various cancer treatment modalities available, radiotherapy is the most commonly used for managing metastatic disease in the brain. Until recent years, this was almost exclusively limited to whole-brain radiotherapy (WBRT). Radiosurgery has emerged as a powerful technique for controlling small to moderate-sized brain metastases (<4 cm in diameter). Tumor control rates with radiosurgery are superior to those with WBRT and appear to equal or surpass those with surgery plus WBRT in most studies. The choice among various radiation management strategies (radiosurgery alone, radiosurgery plus WBRT, or surgery followed by radiotherapy) should be based on the size and location of the brain metastases, the functional and neurologic status of the patient, the type of tumor, the tumor imaging characteristics, and the patient's concerns about the risks and side effects of the proposed treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11595116     DOI: 10.1007/s11912-001-0069-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  25 in total

1.  Solitary brain metastasis. American College of Radiology. ACR Appropriateness Criteria.

Authors:  J S Loeffler; W D Bloomer; J A Buckley; P H Gutin; A W Malcolm; K D Schupak; D Larson; L E Gaspar; F A Gibbs; A A Lewin; W M Mendenhall; J F Schneider; E G Shaw; J R Simpson; M D Wharam; L Rogers; S Leibel
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors:  E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

3.  MR imaging response of brain metastases after gamma knife stereotactic radiosurgery.

Authors:  A M Peterson; C C Meltzer; E J Evanson; J C Flickinger; D Kondziolka
Journal:  Radiology       Date:  1999-06       Impact factor: 11.105

4.  Relationship between pattern of enhancement and local control of brain metastases after radiosurgery.

Authors:  K A Goodman; P K Sneed; M W McDermott; C Y Shiau; K R Lamborn; S Chang; E Park; W M Wara; D A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-05-01       Impact factor: 7.038

5.  Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

Authors:  P K Sneed; K R Lamborn; J M Forstner; M W McDermott; S Chang; E Park; P H Gutin; T L Phillips; W M Wara; D A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-02-01       Impact factor: 7.038

6.  Brain metastases in patients with no known primary tumor.

Authors:  S Maesawa; D Kondziolka; T P Thompson; J C Flickinger; L Dade
Journal:  Cancer       Date:  2000-09-01       Impact factor: 6.860

7.  Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.

Authors:  R Komaki; C A Meyers; D M Shin; A S Garden; K Byrne; J A Nickens; J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

8.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

Authors:  E M Noordijk; C J Vecht; H Haaxma-Reiche; G W Padberg; J H Voormolen; F H Hoekstra; J T Tans; N Lambooij; J A Metsaars; A R Wattendorff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-07-01       Impact factor: 7.038

9.  Stereotactic radiosurgery for brain metastasis from renal cell carcinoma.

Authors:  Y Mori; D Kondziolka; J C Flickinger; T Logan; L D Lunsford
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

10.  RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.

Authors:  Edward Shaw; Charles Scott; John Suh; Sidney Kadish; Baldassarre Stea; John Hackman; Andrew Pearlman; Kevin Murray; Laurie Gaspar; Minesh Mehta; Walter Curran; Michael Gerber
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

View more
  6 in total

1.  Radiation-induced temporary hair loss as a radiation damage only occurring in patients who had the combination of MDCT and DSA.

Authors:  Yoshimasa Imanishi; Atsushi Fukui; Hiroshi Niimi; Daisuke Itoh; Kyouko Nozaki; Shunsuke Nakaji; Kumiko Ishizuka; Hitoshi Tabata; Yu Furuya; Masahiko Uzura; Hideto Takahama; Suzuo Hashizume; Shiro Arima; Yasuo Nakajima
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

2.  Gamma Knife radiosurgery combined with stereotactic aspiration as an effective treatment method for large cystic brain metastases.

Authors:  Hongwei Wang; Songtao Qi; Changwu Dou; Haitao Ju; Zhanbiao He; Qinghai Ma
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

3.  Gamma knife radiosurgery after stereotactic aspiration for large cystic brain metastases.

Authors:  Won Hyoung Park; In Seok Jang; Chang Jin Kim; Do Hoon Kwon
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

Review 4.  [Intracranial cystic lesions].

Authors:  F Ahlhelm; K Shariat; S Götschi; S Ulmer
Journal:  Radiologe       Date:  2018-02       Impact factor: 0.635

Review 5.  Characteristics and treatments of large cystic brain metastasis: radiosurgery and stereotactic aspiration.

Authors:  Moinay Kim; Stephanie Cheok; Lawrance K Chung; Nolan Ung; Kimberly Thill; Brittany Voth; Do Hoon Kwon; Jeong Hoon Kim; Chang Jin Kim; Stephen Tenn; Percy Lee; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2015-04-29

6.  Clinical Outcomes of Gamma Knife Radiosurgery for Metastatic Brain Tumors from Gynecologic Cancer : Prognostic Factors in Local Treatment Failure and Survival.

Authors:  Hong Kyung Shin; Jeong Hoon Kim; Do Heui Lee; Young Hyun Cho; Do Hoon Kwon; Sung Woo Roh
Journal:  J Korean Neurosurg Soc       Date:  2016-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.